Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
02 Dec 2024 07:00 AM
RNS
Total Voting Rights
22 Nov 2024 02:56 PM
RNS
Grant of options
18 Nov 2024 07:00 AM
RNS
Board Changes
15 Nov 2024 07:00 AM
RNS
OXB to present at Jefferies Healthcare Conference
05 Nov 2024 02:23 PM
RNS
Grant of options
04 Nov 2024 10:56 AM
RNS
Holding(s) in Company
01 Nov 2024 07:00 AM
RNS
Total Voting Rights
31 Oct 2024 07:00 AM
RNS
Holding(s) in Company
21 Oct 2024 09:47 AM
RNS
Block Listing Application
04 Oct 2024 03:25 PM
RNS
Grant of Options
03 Oct 2024 04:05 PM
RNS
Holding(s) in Company
01 Oct 2024 05:33 PM
RNS
Holding(s) in Company
01 Oct 2024 07:00 AM
RNS
Total Voting Rights
23 Sep 2024 07:00 AM
RNS
Interim Results
18 Sep 2024 07:00 AM
RNS
Oxford Biomedica rebrands as OXB
02 Sep 2024 07:00 AM
RNS
Lucinda Crabtree joins OXB as CFO today
02 Sep 2024 07:00 AM
RNS
Total Voting Rights
09 Aug 2024 11:01 AM
RNS
Director Declaration
08 Aug 2024 07:00 AM
RNS
Half Year Trading Update and Notice of Results
01 Aug 2024 07:00 AM
RNS
Total Voting Rights
30 Jul 2024 04:51 PM
RNS
Director Declaration
29 Jul 2024 04:31 PM
RNS
Director Declaration
29 Jul 2024 04:31 PM
RNS
Director Declaration
25 Jul 2024 07:00 AM
RNS
Block Listing Application
25 Jul 2024 07:00 AM
RNS
OXB Appoints Non-Executive Director
22 Jul 2024 07:00 AM
RNS
Holding(s) in Company
17 Jul 2024 07:00 AM
RNS
OXB announces CFO transition
03 Jul 2024 09:19 AM
RNS
Person Closely Associated Dealing
01 Jul 2024 11:24 AM
RNS
BLOCK LISTING RETURN
01 Jul 2024 07:00 AM
RNS
Total Voting Rights
28 Jun 2024 04:02 PM
RNS
Holding(s) in Company
27 Jun 2024 01:57 PM
RNS
Person Closely Associated Dealing
24 Jun 2024 05:44 PM
RNS
Result of Annual General Meeting
21 Jun 2024 03:11 PM
RNS
Holding(s) in Company
20 Jun 2024 12:24 PM
RNS
Holding(s) in Company
20 Jun 2024 10:45 AM
RNS
Holding(s) in Company
20 Jun 2024 09:15 AM
RNS
Holding(s) in Company
19 Jun 2024 08:00 AM
RNS
Admission of Shares and Total Voting Rights
18 Jun 2024 07:00 AM
RNS
Subscription of shares by Institut Mérieux
03 Jun 2024 07:00 AM
RNS
Total Voting Rights
15 May 2024 03:52 PM
RNS
2024 Annual General Meeting Notification
01 May 2024 07:00 AM
RNS
Total Voting Rights
30 Apr 2024 05:00 PM
RNS
2023 Annual Report and Accounts
29 Apr 2024 09:38 AM
RNS
Prelim Results for Y/E 2023 - REPLACEMENT
29 Apr 2024 07:00 AM
RNS
Preliminary results for the year ended 31 Dec 2023
02 Apr 2024 07:00 AM
RNS
Total Voting Rights
20 Mar 2024 07:00 AM
RNS
Update on CDMO Services
11 Mar 2024 07:00 AM
RNS
Board Changes
05 Mar 2024 07:00 AM
RNS
Updated Financial Guidance and 2023 Trading
01 Mar 2024 07:00 AM
RNS
Total Voting Rights

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings